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Background: Relapse in people with schizophrenia is a major challenge for mental health service providers in
Tanzania and other countries. Approximately 10% of people with schizophrenia are re-admitted due to relapse at
Muhimbili National Hospital (MNH) Psychiatric Unit each month. Relapse brings about negative effects and it results
in a huge burden to patients, their families, the mental health sector and the country’s economy. So far no study
has been done to address relapse in Tanzania. The purpose of the study was to explore perspectives on risk and
protective factors influencing relapse of people with schizophrenia and their caregivers attending Muhimbili
National Hospital Psychiatric Out-patient Department, Dar es Salaam, Tanzania.
Methods: A qualitative study was conducted, involving in-depth interviews of seven people with schizophrenia
who are out-patients and their seven family caregivers at MNH. Purposive sampling procedure was used to select
participants for the study. Audio recorded in-depth interviews in Swahili language were conducted with all study
participants. The recorded information was transcribed and analyzed using NVivo 9 computer assisted qualitative
data analysis software.
Results: Personal risk and protective factors for relapse, environmental risk and protective factors for relapse and
suggestions to reduce relapse were the main themes that emerged from this study. People with schizophrenia and
their caregivers (all of whom were relatives) perceived non adherence to antipsychotic medication as a leading risk
factor of relapse; other risks included poor family support, stressful life events and substance use. Family support,
adherence to antipsychotic medication, employment and religion were viewed as protective factors. Participants
suggested strengthening mental health psycho-education sessions and community home visits conducted by
mental health nurses to help reduce relapse. Other suggestions included strengthening the nurse-patient
therapeutic relationship in provision of mental health care.
Conclusions: This study calls for improvement in mental health care service delivery to individuals with
schizophrenia. Establishing a curricular in mental health nursing that aims to produce competent mental health
nurse force would improve nursing practice in mental health care service delivery.
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Schizophrenia is a disabling group of brain disorders char-
acterized by symptoms such as hallucinations, delusions,
disorganized communication, poor planning, reduced mo-
tivation, and blunted affect [1]. Schizophrenia is often
accompanied by relapse even while on treatment [2]. Re-
lapse has been defined as a worsening of psychopatho-
logical symptoms or rehospitalization in the year after
hospital discharge [3]. Schizophrenia follows a variable
course, with complete symptomatic and social recovery in
about one-third of cases. Schizophrenia can however fol-
low a chronic or recurrent course, with residual symptoms
and incomplete social recovery. Individuals with chronic
schizophrenia constituted a large proportion of all resi-
dents of mental institutions in the past and still do where
these institutions exist [4].
Relapse may result in hospitalization, treatment resist-
ance, cognitive impairment due to progressive structural
brain damage personal distress incarceration and interfer-
ence with rehabilitation efforts [5]. A few studies regard-
ing relapse and schizophrenia have been done in Africa.
Research in South Africa has found that presence of a co-
morbid depressed mood, poor medication adherence due
to a lack of patient insight and side-effects appear to be
the factors most likely to increase the risk of a relapse [6].
Tanzania’s national hospital’s Department of Psychiatry,
admits about 150 patients with different psychiatric disor-
ders per month: 15 (10%) of these are readmissions due to
relapse in schizophrenia. Apart from patients attending
the clinic for follow-up, approximately 15 patients with
specific psychiatric problems are attended per day within
the department. The number of patients needing mental
health and psychiatric care overloads the available mental
health care team.
Most drugs available in the Psychiatric Unit are typical
antipsychotics which have a lot of extrapyramidal side
effects. Availability of atypical antipsychotics (most com-
monly Risperidone and Olanzepine) with lesser extra-
pyramidal side effects varies; hence patients have to buy
the drugs for themselves. Sometimes they cannot afford
to buy them due to poor social economic status which is
made worse by the mental illness hence they go without
medications which results into relapse. The structure of
in-patient unit does not allow for a good and quality
therapeutic nurse- patient relationship and communica-
tion. This kind of structure prevents nurse- patient
interaction and hinders nurses’ exploration of patients’
problems and concerns which if identified in advance
can lead to interventions that can perhaps help to re-
duce relapse.
Community mental health services are not well estab-
lished. The absence of these services deprives the commu-
nity from benefits of case management, outreach clinics,
family visits, family therapies; counseling and otherpsychotherapies, which would also help reduce relapse
in the community. Relapse in schizophrenia has a lot
of effects to patients, care givers, the health sector and
the country economy at large. Patients tend to deteri-
orate in their level of functioning with each relapse;
hence their contribution to economic activities dimin-
ishes. Caregivers have to take care of the patient’s bills
in the hospital once readmitted which becomes very
costly. The health sector is imposed with a large bur-
den and has to deal with the higher number of patients’
re-hospitalization. Therefore exploration of risk and
protective factors for relapse among people with schizo-
phrenia is a prerequisite in promoting mental health and
preventing relapse in schizophrenia. However studies for
schizophrenia especially on risk and protective factors for
relapse are rare in Africa, including Tanzania. This study
is intended to start addressing that need.
Methods
Design
A descriptive qualitative method was used to explore
and aid understanding of the risk and protective factors
for relapse in people with schizophrenia. Out-patients
with schizophrenia and their caregivers were involved in
the study.
Setting
The catchment area of the study was in Dar es Salaam
Region, Tanzania. The whole country has a population
of about 43 million [7] and it is found in East Africa.
Dar es Salaam region has a population of about 3.1 million
people [8].
Procedure
Sampling of participants to be enrolled in the study took
place at MNH Psychiatric Outpatient Department (OPD).
Sampling was done to the point at which no new informa-
tion was obtained from participants and redundancy was
achieved, i.e. data saturation [9]. Seven adult out-patients
and their seven caregivers were purposefully selected for
the study. Participants of diverse demographic characteris-
tics (age, sex, marital status) were sought in order to ob-
tain maximum variation. All patients had a diagnosis of
schizophrenia according to DSM-IV criteria for more than
6 months and had a history of two or more psychiatric
hospitalizations. With the help of the mental health nurse
in-charge, participants were selected by going through
files of patients with appointments that day, to identify
those who met the study inclusion criteria.
Caregivers were the key guardian for the patient. They
were 18 years of age and above; and had lived with the
patient in the same household for more than 6 months.
Selection of caregivers was done by identifying those
who had escorted the selected patients to the OPD.
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their contacts such as phone numbers for subsequent
booking of the appropriate day and venue for the inter-
view. Participants who were ready to be interviewed on
the same day, agreed to meet the researcher after having
been attended by a psychiatrist. Patients who had come
alone were asked to provide phone numbers for contact-
ing their caregivers so as to book for the appropriate day
and venue for the interview.
Interviews
Eligible participants were given full explanation of the
study, and its importance. They were also informed of the
data collection procedures which involved audio recording
of in-depth interviews (IDIs). All interviews were con-
ducted in Swahili.
For patient interviews, the topic guide was as follows:
 What would you say are the reasons that you
experience relapses?
 How does each of these reasons affect you?
 What assists you to cope with this illness that could
protect you from relapse?
 How does each of these factors assist you to cope?
 What makes it difficult for you to cope with this
illness?
 How does each factor make it difficult for you to
cope?
 What suggestions would you like to make to the
mental health nurses regarding relapse reduction or
prevention?
The topic guide for the caregivers was as follows:
 What would you say are the reasons for your relative
to experience relapses?
 How does each of these reasons affect him/her?
 What assists your relative to cope with this illness
that could protect him/her from relapse?
 How does each of these factors assist him/her to
cope?
 What makes it difficult for the patient to cope with
this illness that could contribute to relapse?
 How does each factor make it difficult for him/her to
cope?
 What suggestions would you like to make to the
mental health nurses regarding relapse reduction or
prevention?
The interviews covered items in the topic guide and any
additional material that was spontaneously suggested by
participants. To gain maximum information, all partici-
pants were encouraged to give their own detailed personalaccount of relapse experience. Individual perceptions
from participants, was obtained by interviewing patients
and their caregivers separately, one after the other. Field
notes were taken by the researcher throughout the inter-
views. The interviews ranged from approximately 30 to
45 minutes.
Ethical considerations
Ethical approval was obtained from the ethical board of
Muhimbili University of Health and Allied Sciences
(MUHAS). Permission to conduct the study was obtained
from the Executive Director of Muhimbili National Hospital
(MNH), and subsequently the Head of Department,
Psychiatry. Participants who agreed to participate in the
study were requested to complete the written informed
consent form, and arrangements for an interview with
each potential participant were then made. Confidentiality
and freedom to withdraw at anytime during the study was
ensured.
Data analysis
Demographic information was analyzed descriptively. In-
formation from the field notes was incorporated into the
data. The interview transcripts were examined in totality,
to obtain an overall sense of the content of the responses
by the participants to various issues. Audio-recorded in-
terviews were transcribed to text computer files. The ac-
curacy of the transcribed data was checked by listening to
the recorded interviews. Minor mistakes were corrected.
Swahili transcripts were used for analysis to maintain
the originality of the data. Content analysis of the data
was done using NVivo 9 computer assisted qualitative
data analysis software. Transcribed interviews (sources)
were imported into the software for analysis.
Trustworthiness
In describing trustworthiness the concepts of credibility,
dependability and transferability were used [10]. Credibility
in this study was covered in various ways:
1. Interviews were conducted until data saturation was
achieved, this provided deeper information about
the phenomenon under study;
2. Data triangulation [11] was used and it was achieved
by investigating the patients’ files; and by
interviewing people with schizophrenia and their
caregivers about the same topic.
3. To ensure dependability [10], an interview guide was
used to ensure consistency during data collection.
Results
Participants’ characteristics can be seen on Table 1. Four
major themes (personal and environmental risks and pro-
tectors) emerged from the data (See Figure 1).
Table 1 Characteristics of patients and their caregivers at MNH, Psychiatric Clinic




P1 36 M Secondary College student Single Son Modicate 25 mg 1/12 >5
C1 69 F Primary Retired nurse Widow Mother >5
P2 40 M Secondary Nursery school teacher Divorsed Brother Chlopromazine 100 mg nocte >5
C2 37 M College Primary school teacher Married Brother >5
P3 55 F Primary Peasant Married Sister inlaw Haloperidol 1.5 mg OD 3
C3 45 F Secondary Bussiness woman Married Sister inlaw 3
P4 30 F Primary None Divorced Daughter Haloperidol 1.5 mg Am & 3 mg
nocte, Artane 5 mg OD
>5
C4 79 M Primary Retired Widower Father >5
P5 56 F Primary Bussiness woman Married Wife Haloperidol 3 mg BID >5
C5 67 M Primary Mechanic Married Husband >5
P6 25 M Primary Cook Single Son Olanzepine 10 mg OD 3
C6 45 F Primary Food vender Divorced Mother
P7 27 M Secondary Business man Single Brother Haloperidol 1.5 OD 2
C7 31 F Secondary Business woman Married Sister
Note: “P” stands for patient and “C” stands for caregivers.
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These are factors within the individual that increases the
likelihood of experiencing relapse.
Poor antipsychotic drug adherence
One of the main factors described by patients to have
caused a number of relapses was poor adherence to anti-
psychotic medications. Non-adherence was due to the
severity of drug side effects, forgetfulness, belief of cure,
expense and lack of supervision.Figure 1 Main nodes (categories) and subcategories of the influencinAll patients stated that the reason they sometimes do
not take their medication is because of the drug side ef-
fects. Patients expressed their concerns about how drug
side effects trouble them and disturb their normal lives.
A male patient, 40 years of age, experiencing muscular
rigidity acknowledged:
….I have problems with my legs, nowadays they
become numb, they tighten. Even walking is
difficult……”g factors of relapse identified in this study.
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effects of the antipsychotics. A male aged 37 years said
about his brother:
Many times he has been saying that, "I have a
numbness problem"
It was also said by several patients and some of the
caregivers that at times patients forget to take their med-
ications which in turn results into relapse. A lack of
supervision and reminders were also found to be a cause
for relapse. A 36 year old male patient said:
“…. You find that I have forgotten to take my
medication, somebody has to insist that I take
medication….”
Patients indicated that they stopped taking their medi-
cation after seeing that they are cured. This was sup-
ported by the fact that they no longer experienced the
disease symptoms they had before. This belief led to
stopping the medication and relapse followed. A 55 year
old female patient, claimed:
“Yes, I used medication, but when I felt that I was
cured I stopped…. I was coming to the clinic but when
I felt cured I stopped attending. I felt I was cured.”
A patient’s mother, aged 45 years, expressed her concern
about how atypical antipsychotics are expensive. Hence
due to poor social economic status and lack of support
from other relatives at times the patient is compelled to
go without medications because the mother alone cannot
afford to buy the medication. This leads to relapse.
Yes they changed to other drugs which are too
expensive; now we have to buy. When the drugs were
finished, he went on without his medicine for a couple
of months. The condition recurred because the
financial situation was difficult.
A 30 year old female patient also claimed that at times
she stops taking medication because there is nobody to
supervise her, despite the fact that she has been told
about the importance of medication, frequency, and dosage.
My father was at work at that time. There was nobody
to supervise me.
Substance use
Smoking "cigarettes" (bhangi, local name for cannabis)
was identified to be a precipitator of relapse by a 25 year
old male patient.This problem started because I used to smoke “sigara
kubwa” (the big cigarette, a local name for cannabis).
Whenever I smoked, I became confused.
Anger
Patients and caregivers expressed their concern about
how anger has resulted into relapse. A 56 year old female
patient said:
“When somebody gives you an unpleasant reply you
become angry…. for example when somebody answers
you rudely…I get angry. I carry it in my head and I
get confused (nachanganyikiwa).”
Another caregiver 31 years of age, reflected:
“Whenever he got angry or whenever he was furious,
that condition used to recur.”
Personal protective factors for relapse
Protective factors of relapse are individual factors that
make it less likely for relapse to occur. The presence of
such factors in an individual with schizophrenia was be-
lieved to reduce the risk of relapse in such individuals.
Antipsychotic drug adherence
Apart from side effects, patients and their caregivers de-
scribed the importance of adhering to antipsychotic
medication and the role it plays in preventing relapse. A
patient’s husband reflected:
“She uses medication well. When she does so her
condition improves… if she follows medication
instructions, she gets no problems.”
Patients and their caregivers also said that the use of
long acting injectables, especially Modicate (Fluphen-
azine decanoate), helps to alleviate psychotic symptoms
and reduce the number of relapses. These types of drugs
also make it easier for them to adhere to the treatment
regimen than the oral antipsychotics.
Frankly at times I get confused, but after I have
been injected, all the things I had done before come
to an end. I truthfully go to school, I learn and
come back home. I participate in several activities
at home.
The patient’s mother supported this by saying:
“When he uses Modicate, we seldom come to the
hospital due to disease symptoms.”
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Patients stated that their religious activities help to im-
prove their condition. A 36 years old male patient said:
“When I go for the choir I interact with my fellow choir
singers; it usually helps me to be active, and you find
yourself okay just like other people.”
Another male patient aged 40 years added:
“For sure it is because I am a very religious person;
therefore, I take my religion book and read. It
strengthens perseverance.”
Employment
Caregivers claimed that when patients engage themselves
in different economic activities to earn a living they feel
free to spend their income because they do not have to
ask others for financial support. This boosts their self es-
teem makes them independent and prevent psychological
problems which may precipitate relapse. It also gives them
the ability to support their families. A patient’s husband
expressed:
“Ever since her youth she is not somebody who would
sit and wait to be served, she is a person who works…..
When she does her work she feels free.”
This was supported by another patient’s sister in-law
caregiver who said:
“She is a peasant…being a peasant helps her because
firstly, it keeps her busy. She does not have the time to
sit and think.”
A 25 year old male patient expressed that his job helps
him to earn a small amount of money to cater for their
basic needs, such as medication which helps reduce disease
symptoms and prevent relapse episodes.
It helps in those days that I do not get medicine from
the hospital; I get to buy my own medicine.
Environmental risk factors for relapse
Several environmental factors were also viewed to have
negative effects on patients’ recovery. Such factors in the
environment trigger for the return of psychotic symptoms.
Inadequate family support
Some patients complained about criticism from their
caregivers and that they are not supported in times of
need. This tends to disturb them psychologically and
as a result they tend to relapse due to the lack ofsupport in treatment regimen. A 40 year old male pa-
tient claimed:
“………I followed him five times, I told him, “Uncle, I
am sick. I am very sick and I cannot get in a bus. It is
very far from Mbagala to Muhimbili. I cannot go on
my own, I need somebody to hold my hand because
standing in a bus is very difficult for me. So I ask you
to help me and take me to the hospital.” But he
refused, just like that.”
One female caregiver (patient’s mother) expressed her
concern about how it is difficult for her and the patient
to get support from other relatives. This lack of support
especially financially, makes it difficult for the caregiver
and patient to obtain medication whenever they are re-
quired to purchase. As a result the patient relapses be-
cause of failure to obtain medication. She complained:
“It is difficult to make a decent life……his father is
already dead and his relatives on his father's side
(upande wa kiumeni) nobody does anything to help
or support him.” (She cried silently while wiping off
her tears).
Stressful life events
One patient declared that she had experienced a number
of relapses manifested by recurrence of symptoms after
having a miscarriage and also after losing a baby during
birth.
The first time I was pregnant and I got a miscarriage
at three months, I started to get confused
(nilivurugikiwa)……. After the miscarriage then I
found as if I was confused mentally and I saw as if the
earth was changing…….I became fine but then I got
pregnant again, I was brought to Muhimbili, I gave
birth but the baby did not survive, I was confused once
again.
One female patient, aged 56 years, claimed that one of
the reasons she experiences relapse is when she thinks
about things she has not accomplished in life.
At times I think; I have not even built my own hut
(kibanda). I then think about what I should do so that
I can get my hut, I think, I want my children to be like
this or I want my husband to be like this…
The patient’s husband added:
“Her problem was about thinking about things which she
is not certain to get….and when she does not get them; it
disturbs and confuses her (anachanganyikiwa)…..”
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Environmental protective factors are within the individ-
uals’ surroundings that tend to make it less likely that re-
lapse will occur. Participants gave different views on
factors in the environment that tended to protect them
from relapse; these included family and peer support,
and mental health services.
Family support
More than half of all patients indicated that the presence
of support and love from their family, neighbors and the
community reduced the number of relapse episodes. A
36 year old male patient declared:
“On my family's side for example, honestly they all
care for me very much. They don't like to see me reach
a state of confusion. That is why they bring me to the
hospital when they see that I have reached a bad
state”
This was supported by a female patient aged 55 years
old.
“Ah! My relatives help me so much. Firstly those
relatives are the ones who saved me, because I did not
know myself……I had been suffering….They show a lot
of love. They do stigmatize me. (kunyanyapaa) a
patient.”
Peer support
Peer support was shown to play a big part in keeping
the patient better and also in protecting the patient from
relapse. One patient aged 25 years declared:
“I have friends, who comfort me and support me.
Whenever I get sick, many of them come to visit.”
A female caregiver (patient’s sister) said:
“I noticed that his friends help him because they have
not discriminated against him…..When he is with
them they talk like they used to prior to the illness.”
Mental health services
The majority of patients and their care givers confirmed
that the mental health services they receive help a lot.
They acknowledged that, If those services were un-
available the condition of the patient would not have
improved.
“Mental health services help a lot. Good services begin
from when we receive mental health education up to
when they provide us with medication.”Suggestions to reduce relapse
Several suggestions were made by participants to reduce
relapse. The main suggestion was the improvement of
mental health services with much emphasis on commu-
nity home visits, strengthening of provider-patient thera-
peutic relationship, and psychoeducation.
Community home visits
Patients suggested that substantial recovery will occur
and relapses could be prevented if mental health nurses
followed them to their homes in the community to know
the progress of their illness. Community services would
yield clear information about the condition of the pa-
tient. The course of the illness would be monitored and
the cause of their illnesses would be identified. One pa-
tient said:
“For example I think I would suggest that mental
health nurses should make follow up at our homes
because waiting here brings ambiguity (utata) because
the patient says this and the caregivers say that.
Therefore it is difficult for one to know what to follow”
The patient’s mother added:
“It would be good if you (mental health nurses) would
visit us at our homes. That would be very good. You
would talk to the patients, find out how he has been
since the other day, and how one feels.”
A 37 year old male caregiver (patient’s brother) suggested
that mental health nurses should educate families with
mentally ill patients on the risk factors to mental illness.
“When it is known that this problem has been
inherited, then those in the family should be called. So
they can be told that this problem is in the clan and it
can happen to anyone.”
Caregivers urged that mental health workers should
try their best to get enough time and talk to the patients
and caregivers. They also suggested that at times it
would be beneficial to communicate with them through
cell phones; that way they could urge them to come or
to set appointments for such talks for the betterment of
the patient’s condition.
“……..What I would like to be done is for the patients
and their caregivers to get enough time for mental
health counseling.”
Provider-patient therapeutic relationship
A 45 year old female caregiver (patient’s sister in-law) sug-
gested that the time the patients spends with a psychiatrist
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allow the mental health provider to talk and listen to the
patient's concerns and needs. The mental health nurses,
physicians or psychiatrists should spend enough time with
patients to get to know their mental conditions.
“….If you talk with the patient like this you get to
know the patient rather than when the patient arrives;
you just take the card, you write eeeh how have you
been!, you write tatatata.....come at a certain date….
But when you take time to talk to the patient, I think
you can know more about his or her condition.”
A patient’s sister recommended that all mental health
workers should try their best to use pleasant language
when interacting with clients when they come to seek
mental health care because the language itself is thera-
peutic to the patient.
“I am asking you to educate each other that when you
take care of somebody a pleasant language is preferred
even before you provide medication to that person.”
Discussion
The study highlighted relapse concerns facing schizo-
phrenic patients and their caregivers in Dar es Salaam.
The findings suggested that both patients and caregivers
perceived non adherence to antipsychotic medication as
a leading factor of relapse. Others included inadequate
family support, stressful life events and substance use.
Adherence to antipsychotic medication, family and peer
support, employment and religion were perceived to
protect patients from relapse episodes. Psychoeducation,
community home visits and a good therapeutic relation-
ship could help reduce relapse and promote mental health
in patients with schizophrenia.
Risk factors for relapse
Non adherence to antipsychotic medication
Non compliance to antipsychotics was demonstrated to
be an important factor that resulted in relapse of several
patients. Previous studies have also found that non ad-
herence appears to be one of the factors most likely to
increase the risk of relapse in schizophrenic patients [6].
Medication noncompliance and under-compliance con-
tinues to be a problem in the treatment of schizophrenia
in the United States and Canada; the vast majority of
hospital admissions for exacerbation of psychosis have
been linked to noncompliance [12]. In Germany it has
been found that patients who tend to experience a re-
lapse are less likely to have a positive attitude toward
treatment adherence [3].
The majority of patients in this study were on typical
antipsychotic medication and they reported at least oneside effect that was at least somewhat bothersome. Typical
antipsychotic drugs are likely to produce exrapyramidal
side effects and akathisia, which may directly lead to non-
adherence [13]. Patients in Dar es Salaam reported sed-
ation and exrapyramidal side effects such as rigidity, and
tremors, which is consistent with prior research [14,15].
Taking medication daily is a burden for these individuals,
which is made worse by the side effects of these drugs. In
an effort to get rid of these discomforts, individuals stop
taking their regular medication which in turn causes them
to experience relapse. Providing education with emphasis
on the importance of medication would help these indi-
viduals to be responsible of the medication management
process.
The interviews of half of patients revealed lack of on-
going assessment. These patients had stopped attending
the psychiatric unit for follow up visits, several times.
They had also stopped taking medication believing their
symptoms had resolved [16] and that they were cured.
Lack of awareness among families about the nature of
the illness also contributes to discontinuation of treatment.
In India when the symptoms were controlled and the
patient had recovered sufficiently to become functional,
he was seen as being "cured" and no longer in need of
treatment [17].
Inadequate family support
Low perceived social support among caregivers has been
associated with relapse among mentally ill clients [18].
The family factor is one of the psychosocial factors that
affects the clinical course and outcome of schizophrenia
including its recurrence. Social support deficits are risk
factors for non-adherence in schizophrenia. Persons who
live alone may lack medication supervision and have diffi-
culty accessing medical care. Lack of support from family
might hinder persons with schizophrenia in achieving re-
habilitation [13]. Poor family support in individuals with
mental illness may be evidenced by clients being denied
food, laughed at and even beaten at other times [19].
Family members may not support the client because
they would not want to share some of the property the
patient owns. Hence they tend to ignore the patient’s
symptoms and treatment a practice which results into
relapse [20].
Stressful life events
Several patients from the study reported that unfavorable
events in their lives have in one way or another contrib-
uted to a number of relapses in their lives. These events
included loss of a child during birth, miscarriage, being
angered by care givers, and criticism from care givers.
These results are consistent with previous studies that
have found that patients with schizophrenia are more sen-
sitive and more susceptible to the negative effects of even
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with the onset of a psychotic relapse, usually in the 3 weeks
prior the relapse [6].
One patient expressed his concern on how he received
critical comments from his care givers and how these
comments made him feel. It has been shown that pa-
tients from families with high criticism had a signifi-
cantly higher number of psychiatric readmissions and
longer cumulative length of stay at psychiatric hospitals
than patients from families with low criticism [21]. High
criticism has been found to be associated significantly
with poorer outcome and a worse course of illness than
those who did not feel criticized [21]. The results are
also consistent with a study that was done by [22]. Pa-
tients with schizophrenia expressed increased stress re-
lating to their domestic environment, which was a result
of interpersonal conflicts between patients and their par-
ents, children, neighbors or extended family members.
Substance use
Cannabis use was found to be a factor that was believed
by one patient to have precipitated relapse. Studies in
Germany have also shown that second to alcohol, cannabis
is the most frequently misused substance among patients
with schizophrenia [23]. In patients with an established
psychotic disorder cannabis abuse is associated with a
higher risk of psychotic relapses and with poorer social
outcome. Cannabis is also frequently abused by schizo-
phrenic patients, and it is associated with worse clinical
out-comes [24]. Given that psychoactive compounds
within cannabis can cause or increase psychotic experi-
ences secondary to intoxication effects [25] it is very
plausible that cannabis might lead to increased positive
symptoms and subsequently relapse or re-hospitalization
in people with psychosis.
It has also been suggested that schizophrenic patients
are more vulnerable to the effects of tetrahydrocannabinol,
which is the main psychotropic compound of cannabis.
Cannabis use has been reported to increase delusions
and hallucinations in people with schizophrenia, while
the findings regarding negative symptoms have been
contradictory [26].
Protective factors for relapse
Family and peer support
Importance has been given to the family environment as
a contributing factor to the relapse or rehabilitation of
the patient. The family is an important factor which af-
fects the patient’s mental well-being and outcome. Sup-
port from family promotes adherence in patients with
mental illness which aids recovery. The kind of support
they provide to clients include medication, supervision,
monitoring the drug intake and taking the patients to
mental health facilities regularly [27].The family support networks were reported as strong
by more than half of the participants in this study. Pa-
tients were very grateful for the support they received
from their care givers during their illness episodes, when
attending the clinic for follow up visits, encouragement
and supervision when taking their medication and in ful-
fillment of other basic needs of life like education, em-
ployment, and health in general. These results are in
agreement with a study of 121 patients and their 121
family members in Japan which found that more than
70% of the families replied that they ‘often’ or ‘some-
times’ supported the patients in mental health manage-
ment and daily living such as ‘observation of the
condition’ and ‘taking drugs’ [28].
Helping families to maintain and enhance a supportive
social network may represent a useful means to reduce
family burden in schizophrenia [29]. People with mental
illness receive critical support from family members.
Support and reciprocity with family members are im-
portant elements thet relates to the patient’s recovery
process [30]. Caregivers appreciated the support they re-
ceived from other relatives. Family support tends to re-
duce the burden that caregivers may have to experience
in caring for patients with schizophrenia [31].
Drug adherence
Antipsychotic medication compliance was expressed by
patients and their care givers to be a strong protector of
relapse. It was found that the relapse risk was substan-
tially lower when a patient was adhering properly to the
antipsychotic therapy [12]. Improvement in symptoms
and the recognition of this improvement by patients
may have led to improvement in their attitude to medi-
cation [12]. Furthermore, patients’ subjective attitude to-
ward medication is associated with treatment adherence
and objective measures of symptom responsiveness among
individuals with schizophrenia.
Some patients reported fewer antipsychotic drug side
effects than others. Those who were on atypical anti-
psychotic drugs such as Olanzepine are among patients
who were adherent to medications. This is consistent
with a study which found that fewer side effects, as well
as the effectiveness of atypical antipsychotic drugs in
managing psychotic symptoms, make it more likely that
persons will continue their treatment. Thus, the choice
of antipsychotic drug affects adherence [13].
Religion
Religion was indicated by three patients and their care-
givers to have beneficial impacts in the course of their
illness. They added that religion, including singing in
church choir, creates a sense of belonging, enables them
to deal with difficult situations and gives them the
strength to move on despite their mental conditions.
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religion and spirituality may provide positive coping to
patients with schizophrenia [32]. Promotion of mental
health through religion has been found to be as import-
ant as treatment of mental illness. Religion fosters recov-
ery even when symptoms persist and people with mental
illnesses can be helped to achieve fulfilling, meaningful
and purposeful lives [33].
Religion and spirituality can play an important part in
recovery. Religious activities have been shown to be
helpful in dealing with psychiatric symptoms. Individuals
with mental illness who experience greater symptom se-
verity and lower overall functioning engage more in reli-
gious activities as part of coping with mental problems
[34] which enhances recovery.
The positive impact of spirituality on adherence to
treatment is explained by an improved quality of life, a
better social support, and more positive representations
of the illness by believers. Religion affects the self and
may improve recovery by instilling hope, purpose, and
meaning in life but also affects the adherence to treat-
ment [35].
Employment
This study also found that when patients have a job to
earn income they become independent. This boosts their
self esteem and helps them feel that they can contribute
something to the family or society. The importance of
having meaningful employment has been emphasized in
reflecting patients’ needs to reach personal goals, hopes,
and aspirations, as important components of well-being.
This is believed to contribute to both increased self-esteem
and to better management and reduction of symptoms
including negative, positive, and depressive symptoms
[36]. Having a job tends to keep patients busy; they
tend not to think of their mental illness. Employment
has repeatedly been shown to have an important role
in patients’ recovery from any severe mental illness,
particularly schizophrenia [37].
Employment not only provides income, it also improves
activity and social contacts for patients with schizophre-
nia. It fosters financial benefits; provide coping strategies
for psychiatric symptoms, and ultimately facilitating the
process of recovery from mental illness [37].
Suggestions to reduce relapse
Therapeutic relationship
Therapeutic factors within therapeutic relationships relate
to how the patient reacts to the interventions offered by
the nurse. This reaction is typified by the notion of rap-
port between the patient and the nurse. The rapport refers
to the affinity and emotional closeness between two indi-
viduals and how this is recognized and used in a thera-
peutic way [38].Relationships have been shown to play an important
role in the development of trust [39]. When clients re-
ceive good services they develop trust, which fosters a
sense of belonging and a good relationship, leading to
positive motivation regarding care [40]. Other studies
have found that a good therapeutic relationship between
patients with schizophrenia and mental health profes-
sionals is important for adherence to antipsychotic
medication [41].
Individuals with mental illness often experience pe-
riods of despair related to psychiatric symptoms or psy-
chosocial consequences of having a psychiatric illness.
The presence of someone who can provide hope and
empathy towards an individual’s suffering helps through
these difficult times [42].
Patients and their caregivers from this study suggested
that mental health nurses and psychiatrists should dedi-
cate their time to listen to their concerns so as to im-
prove patients’ conditions. However due to shortage of
well trained mental health nurses at the psychiatric unit,
this kind of relationship may be poorly formulated.
Community home visits
Patients and their caregivers emphasized the importance
of home visits by mental health nurses. They urged that
regular visits would enable them to receive psychoedu-
cation on patient management, drug adherence and side
effects. Regular psycho-education programs must be
conducted in the community to educate the families
about the nature of their relative's illness and the need
for sustained medical treatment [17]. Community visits
have been shown to help patients deal with their symp-
toms, promote relaxation, and help clients take medica-
tion regularly, improve client’s self-care abilities and
improve interactions between clients and families [43].
Psychoeducation
The purpose of patient education/teaching (or psychoe-
ducation) is to increase patients’ knowledge and under-
standing of their illness and treatment. It is supposed
that increased knowledge enables patients with schizo-
phrenia to cope more effectively with their illness [44].
Patients were concerned that medications only would
not reduce the problem of relapse. They urged mental
health nurses to also provide more counseling and psy-
choeducation sessions which would help improve their
condition. Patients who understand their illness, medica-
tions, and treatment expectations consistently demon-
strate better adherence [45].
Caregivers suggested the importance of educating fam-
ilies with mentally ill individuals on risk factors of men-
tal illness so as to protect those who have not developed
symptoms. Psychoeducation programs for patients, fam-
ilies, and caregivers aimed at coping with schizophrenia
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abuse, reduce relapse, and shorten hospital stays [46].
These findings call for improvement in service delivery
for mentally ill individuals especially health education
sessions on the importance of medication adherence and
follow up. Further emphasis should be focused on train-
ing of more mental health nurses who will provide qual-
ity mental health services for inpatient care, outpatient
care, and primary mental health care which meet the
needs of a larger number of individuals with mental ill-
nesses in Tanzania.
Limitations of the study
The results should be transferred with caution as recruit-
ing caregivers who had accompanied patients to the Psy-
chiatric Out-patient Department probably contributed to
inclusion of caregivers with very good relationship with
their patients and interest in patient care. They might have
also given socially desired answers. However the atmos-
phere during the interview indicated honesty. In addition,
the small sample may limit the transferability of the find-
ings particularly in relation to ethnicity and social eco-
nomic conditions. A larger sample of participants with
diverse characteristics could have resulted in different per-
spectives of relapse experience.
Conclusions
This study highlighted the perceptions of patients with
schizophrenia and their caregivers about risk and protect-
ive factors of relapse. The findings call for improvement in
mental health care service delivery to individuals with
schizophrenia. Establishing a curricular in mental health
nursing that aims to produce competent mental health
nurse force would improve nursing practice in mental
health care services. These results can be exploited in in-
fluencing health policy makers to improve mental health
and reduce the burden of relapse in individuals with
schizophrenia, their families and community as a whole.
In addition, the results can help establish clear policies ar-
ticulating measures to reduce relapse in patients with
schizophrenia and then develop systematic plans with
dedicated budget and agreed timelines.
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